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Abstract
Background—Since smoking has a profound impact on socioeconomic disparities in illness and 
death, it is crucial that vulnerable populations of smokers be targeted with treatment. The US 
Public Health Service recommends that all patients be asked about their smoking at every visit, 
and that smokers be given brief advice to quit and referred to treatment.
Purpose—Initiatives to facilitate these practices include the 5 A’s (i.e., Ask, Advise, Assess, 
Assist, Arrange) and Ask Advise Refer (AAR). Unfortunately, primary care referrals are low, and 
most smokers referred fail to enroll. This study evaluated the efficacy of the Ask Advise Connect 
(AAC) approach to linking smokers with treatment in a large, safety-net public healthcare system.
Design—Pair-matched-two-treatment arm group-randomized trial.
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Setting/participants—Ten safety-net clinics in Houston, TX.
Intervention—Clinics were randomized to AAC (n=5; intervention) or AAR (n=5; control). 
Licensed Vocational Nurses (LVNs) were trained to assess and record the smoking status of all 
patients at all visits in the electronic health record (EHR). Smokers were given brief advice to quit. 
In AAC, the names and phone numbers of smokers who agreed to be connected were sent 
electronically to the Texas Quitline daily, and patients were proactively called within 48 hours. In 
AAR, smokers were offered a Quitline referral card and encouraged to call on their own. Data 
were collected between June 2010 and March 2012 and analyzed in 2012.
Main Outcome Measure—The primary outcome – impact – was defined as the proportion of 
identified smokers that enrolled in treatment.
Results—The impact (proportion of identified smokers who enrolled in treatment) of AAC 
(14.7%) was significantly greater than the impact of AAR (0.5%), t (4) = 14.61, p = 0.0001, OR = 
32.10 (95% CI 16.60–62.06).
Conclusions—AAC has tremendous potential to reduce tobacco-related health disparities.
BACKGROUND
Smoking is becoming increasingly concentrated among individuals with the lowest levels of 
education, income, and occupational status,1–6 and has a profound impact on socioeconomic 
disparities in the United States.7–9 Therefore, it is crucial that vulnerable populations of 
smokers be targeted with evidence-based cessation treatment.10 Because evidence-based 
treatments delivered by quitlines are underutilized,11–1510,16 formalizing partnerships with 
healthcare systems has been identified as a critical strategy for enhancing their reach and 
overall impact.16 Despite 5 A’s (i.e., Ask, Advise, Assess, Assist, Arrange) and “Ask Advise 
Refer (AAR)” initiatives,121117181920 treatments have not been well integrated within 
healthcare systems.10,16,21–24 Thus, there is a critical need to address treatment barriers. We 
recently evaluated the efficacy of a new, electronic health record (EHR)-based approach to 
connect smokers in healthcare settings with treatment called “Ask Advise Connect” (AAC). 
Results of our initial trial, conducted in a private healthcare system, indicated that AAC (vs. 
AAR) was associated with a 13-fold increase in treatment enrollment.25 The current study 




A pair-matched group randomized design in 10 Harris Health System community health 
clinics was utilized. The clinics serve nearly 200,000 unique adult patients per year, 90% are 
members of racial/ethnic minority groups, and nearly half have incomes below poverty. Five 
clinics were randomized to AAC (intervention) and five were randomized to AAR (control 
condition). The dissemination period was 18 months. Data were collected between June 
2010 and March 2012 and analyzed in 2012. The protocol was published in 2010.26
Vidrine et al. Page 2














Participants were current smokers ≥18 who were seen the clinics. There was no racial or 
gender bias in participant selection. IRB approval was obtained from MD Anderson Cancer 
Center, Harris Health System, and the Texas Department of State Health Services.
Randomization
Randomization occurred at the clinic level. Clinics were initially paired by the investigators 
based on patient volume, average age, gender, race/ethnicity, and percent below poverty. 
One clinic within each pair was then randomly assigned to one of the two arms.
Procedures
In AAC and AAR, Licensed Vocational Nurses (LVNs) were trained to assess and record 
the smoking status of all patients at all visits in the EHR when vital signs were collected. 
They were also trained to provide smokers with brief advice to quit consistent with the 
Guideline.11 A 30-minute training session on how to assess smoking status, deliver brief 
advice to quit, and connect (AAC) or refer (AAR) patients to the Quitline was held at the 
beginning of the trial. In AAC, LVNs directly connected patients with the Quitline through 
clicking an automated link in the EHR that sent smokers’ names and phone numbers to the 
research team, who then sent the information to the Quitline within 24 hours. Patients were 
contacted by the Quitline within 48 hours. In AAR, LVNs gave smokers willing to accept 
assistance a Quitline referral card.
Smoking status and willingness to be connected (in AAC) or referred (in AAR) were 
recorded using the EHR. An Excel data file was automatically and securely sent to the 
research team daily, and forwarded to the Quitline daily. Treatment enrollment was tracked 
and recorded by the Quitline. Data were maintained in an Access database.
Outcome Measures: Reach, Efficacy and Impact
Reach, efficacy, and impact were evaluated using the RE-AIM framework.27 Reach = 
number of smokers that talked with Quitline / total number of identified smokers. Efficacy = 
number of smokers that enrolled in Quitline treatment / total number of identified smokers 
that talked with Quitline. Impact = Reach × Efficacy.
Data Analysis
Proportions for Reach, Efficacy, and Impact were calculated and the magnitude and 
significance of differences between AAC and AAR were evaluated using Donner and 
Donald’s weighted empirical logistic transformation approach. This approach accounts for 
nesting of individuals within clinics and induced intraclass correlation and was used because 
the data were generated using a pair-matched-two-treatment arm group randomized trial.28 
This method accounts for the probability of imbalance between treatment groups on 
participant characteristics, and provides estimated odds ratios (ORs) for assessing the 
significance of the intervention effects over all strata.
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Smoking prevalence was 16.0% (17,959 / 112,112), and higher in AAC (7,237 / 40,402 = 
17.9%) versus AAR (10,722 / 70,710 = 15.2%), Pearson’s X2(1)=142.8 p=1.3×10−33. 
However, Donner and Donald’s 22 approach accounts for such imbalances and yields results 
robust to such potential biases.
Reach
In AAC, 7,237 smokers were identified, and in AAR, 10,722 smokers were identified. In 
AAC, 23.6% of identified smokers talked with the Quitline (1,707 / 7,237) and in AAR, 
0.5% of identified smokers talked with the Quitline (56 / 10,722). The empirical logistic 
transformation approach indicated that the Reach was significantly greater in AAC (vs. 
AAR), t(4)=18.60, p=.00005.28 The overall estimated odds ratio (OR) and 95% CI for 
assessing the intervention on Reach over all strata was equal to 56.19 (95% CI 30.79–
102.53).
Efficacy
Of the 1,707 smokers that talked with the Quitline in AAC, 1,060 enrolled in treatment 
(62.1% enrollment rate). Of the 56 smokers in AAR that talked with the Quitline, 53 
enrolled in treatment (94.6% enrollment rate). The unconditional test for equivalence of two 
binomial proportions was used to compare treatment enrollment in AAR versus AAC. The 
Efficacy of AAR (vs. AAC) was significantly greater (standardized Z statistic = 4.97, 
p=3.4×10−7.).
Impact
Impact was significantly greater in AAC (23.6% × 62.1% = 14.7%) than in AAR (0.5% × 
94.6% = 0.5%), t (4) = 14.61, p = 0.0001.28 The overall estimated OR for assessing the 
effect of the intervention on impact over all strata was equal to 32.10 (95% CI 16.60–62.06).
CONCLUSIONS
Directly connecting low-income, racially/ethnically diverse smokers to the Quitline via an 
automated link in the EHR resulted in a nearly 30-fold increase in treatment enrollment 
compared to providing referral cards and asking smokers to call on their own. This treatment 
enrollment rate is larger than in any study previously reported. Importantly, AAC yielded a 
larger effect size in a safety-net healthcare system than a private healthcare system (30-fold 
vs. 13-fold increase in treatment enrollment).25 Recent healthcare reform legislation has 
created an environment in which programs such as AAC could be integrated and sustained 
within healthcare settings.29–31
A strength is that AAC was evaluated in a setting representative of real-world healthcare 
systems that serve smokers disproportionately burdened by tobacco. Additionally, AAC 
could be implemented broadly in other healthcare settings. A limitation is that smoking 
outcome data were not collected, and smokers who called the Quitline may have been more 
motivated to quit. Another limitation is the absence of a fidelity check on LVNs. That 
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smoking prevalence (16%) was lower than would be expected in this population, and 
differed between AAC (17.9%) and AAR (15.0%) clinics, suggests that all patients were not 
for smoking status, and that AAC (vs. AAR) clinics may have more systematically screened 
and documented smoking status. Finally, the national infrastructure for supporting quitlines 
would need to be expanded to be sufficient to support widespread adoption of AAC.
In summary, widespread adoption of AAC could reduce tobacco-related morbidity and 
mortality, and the large effect obtained in a safety-net healthcare system supports the 
potential of AAC to reduce tobacco-related health disparities.
Acknowledgements
The project described was supported by Grant Number R18DP001570 (PI: Vidrine) from the Centers for Disease 
Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily 
represent the official views of the CDC. This work was also partially supported by the National Institutes of Health 
through MD Anderson's Cancer Center Support Grant CA016672. MD Anderson’s Patient-Reported Outcomes, 
Survey, and Population Research (PROSPR) Shared Resource also provided support through MD Anderson’s 
Cancer Center Support Grant. Support was also provided by a grant from The University of Texas MD Anderson 
Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment - Center for Community-
Engaged Translational Research.
REFERENCES
1. CDC. Cigarette smoking among adults - Unites States, 2000. MMWR. 2002; 51:642–645. [PubMed: 
12186222] 
2. Wetter DW, Cofta-Gunn L, Fouladi RT, et al. Understanding the associations among education, 
employment characteristics, and smoking. Addict Behav. 2005; 30:905–914. [PubMed: 15893088] 
3. Barbeau EM, Krieger N, Soobader MJ. Working class matters: socioeconomic disadvantage, race/
ethnicity, gender, and smoking in NHIS 2000. Am J Public Health. 2004; 94:269–278. [PubMed: 
14759942] 
4. CDC. Cigarette smoking among adults-United States, 2003. MMWR Morb Mortal Wkly Rep. 2005; 
54:509–513. [PubMed: 15917735] 
5. Hughes JR. The future of smoking cessation therapy in the United States. Addiction. 1996; 
91:1797–1802. [PubMed: 8997761] 
6. Winkleby MA. Accelerating cardiovascular risk factor changes in ethnic minority and low 
socioeconomic groups. Annals of Epidemiology. 1997; S7:S96–S103.
7. Pierce JP, Fiore MC, Novotny TE, Hatziandreu EJ, Davis RM. Trends in cigarette smoking in the 
United States. Educational differences are increasing. Jama. 1989; 261:56–60. [PubMed: 2908995] 
8. Fiore MC, Novotny TE, Pierce JP, Hatziandreu EJ, Patel KM, Davis RM. Trends in cigarette 
smoking in the United States. The changing influence of gender and race. Jama. 1989; 261:49–55. 
[PubMed: 2908994] 
9. Honjo K, Tsutsumi A, Kawachi I, Kawakami N. What accounts for the relationship between social 
class and smoking cessation? Results of a path analysis. Soc Sci Med. 2006; 62:317–328. [PubMed: 
16039765] 
10. Abrams, DB. A comprehensive smoking cessation policy for all smokers: Systems integration to 
save lives and money. In: Bonnie, RJ.; Stratton, K.; Wallace, RB., editors. Ending the Tobacco 
Problem: A Blueprint for the Nation. Washington, D.C.: Institute of Medicine: National 
Academies Press; 2007. Appendix A
11. Fiore, MC.; Jaen, CR.; Baker, TB., et al. Treating Tobacco Use and Dependence: 2008 Update. 
Rockville, MD: U.S. Department of Health and Human Services (USDHHS), Public Health 
Service (PHS); 2008. 
12. Fiore, MC.; Bailey, WC.; Cohen, SJ., et al. Treating Tobacco Use and Dependence: Clinical 
Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services (USDHHS), 
Public Health Service (PHS); 2000. Report No.: 1-58763-007-9.
Vidrine et al. Page 5













13. Stead, LF.; Perera, R.; Lancaster, T. Telephone counseling for smoking cessation (review). New 
York: John Wiley & Sons; 2007. 
14. Ossip-Klein DJ, McIntosh S. Quitlines in North America: evidence base and applications. Am J 
Med Sci. 2003; 326:201–205. [PubMed: 14557735] 
15. Rabius V, McAlister AL, Geiger A, Huang P, Todd R. Telephone counseling increases cessation 
rates among young adult smokers. Health Psychol. 2004; 23:539–541. [PubMed: 15367074] 
16. Borland R, Segan CJ. The potential of quitlines to increase smoking cessation. Drug Alcohol Rev. 
2006; 25:73–78. [PubMed: 16492579] 
17. Ask and Act Tobacco Cessation Program. 2013 at http://www.aafp.org/online/en/home/clinical/
publichealth/tobacco.html. 
18. Bernstein SL, Boudreaux ED, Cydulka RK, et al. Tobacco control interventions in the emergency 
department: a joint statement of emergency medicine organizations. Ann Emerg Med. 2006; 
48:e417–e426. [PubMed: 16997678] 
19. ASA Stop Smoking Initiative for Providers: Smoke-Free for Surgery. at http://www.asahq.org/For-
Members/Clinical-Information/ASA-Stop-Smoking-Initiative.aspx. 
20. Do you cAARd? Ask, Advise, Refer - Help your patients quit smoking. 2006 at http://
www.caldiabetes.org/content_display.cfm?contentID=497&CategoriesID=32. 
21. Bentz CJ, Bayley KB, Bonin KE, Fleming L, Hollis JF, McAfee T. The feasibility of connecting 
physician offices to a state-level tobacco quit line. Am J Prev Med. 2006; 30:31–37. [PubMed: 
16414421] 
22. Solberg LI, Maciosek MV, Edwards NM, Khanchandani HS, Goodman MJ. Repeated tobacco-use 
screening and intervention in clinical practice: health impact and cost effectiveness. Am J Prev 
Med. 2006; 31:62–71. [PubMed: 16777544] 
23. Katz DA, Muehlenbruch DR, Brown RB, Fiore MC, Baker TB. Effectiveness of a clinic-based 
strategy for implementing the AHRQ Smoking Cessation Guideline in primary care. Prev Med. 
2002; 35:293–301. [PubMed: 12202073] 
24. Conroy MB, Majchrzak NE, Silverman CB, et al. Measuring provider adherence to tobacco 
treatment guidelines: a comparison of electronic medical record review, patient survey, and 
provider survey. Nicotine Tob Res. 2005; 7(Suppl 1):S35–S43. [PubMed: 16036268] 
25. Vidrine JI, Shete S, Cao Y, et al. Ask-Advise-Connect: a new approach to smoking treatment 
delivery in health care settings. JAMA Intern Med. 2013; 173:458–464. [PubMed: 23440173] 
26. Vidrine JI, Rabius V, Alford MH, Li Y, Wetter DW. Enhancing dissemination of smoking 
cessation quitlines through T2 translational research: a unique partnership to address disparities in 
the delivery of effective cessation treatment. J Public Health Manag Pract. 2010; 16:304–308. 
[PubMed: 20520368] 
27. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion 
interventions: The RE-AIM framework. American Journal of Public Health. 1999; 89:1322–1327. 
[PubMed: 10474547] 
28. Donner A, Donald A. Analysis of data arising from a stratified design with the cluster as unit of 
randomization. Statistics in medicine. 1987; 6:43–52. [PubMed: 3576016] 
29. Patient Protection and Affordable Care Act. HR-3590 United States. 2009
30. Health Information Technology for Economic and Clinical Health. Title XIII of Division A and 
Title IV of Division B United States. 2009
31. Buntin MB, Jain SH, Blumenthal D. Health information technology: laying the infrastructure for 
national health reform. Health Aff (Millwood). 2010; 29:1214–1219. [PubMed: 20530358] 
Vidrine et al. Page 6















Vidrine et al. Page 7














Reach, Efficacy, and Impact for AAC and AAR
Notes: Reach = proportion of smokers identified who talked with Quitline; Efficacy = 
proportion of smokers who talked with Quitlline that enrolled in treatment; Impact = Reach 
× Efficacy
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